Can antibody shots cure hepatitis b? early trial halted
NCT ID NCT05345990
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study tested whether giving hepatitis B antibodies (HBIG) could clear the hepatitis B surface antigen (HBsAg) from the blood of people with chronic hepatitis B. The trial aimed to enroll 20 adults who had the infection for at least a year and were already on antiviral medication. Participants received weekly antibody injections for 12 weeks. The study was terminated early after enrolling only 13 people, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hannover Medical School, Department for Gastroenterology, Hepatology and Endocrinology
Hanover, Lower Saxony, 30625, Germany
Conditions
Explore the condition pages connected to this study.